The exploitation of photobiology in medicine has been of great interest to mankind. There is a growing interest in the use of lasers for treatment purposes because of the photochemical alterations induced in biomolecules by light energy. In this paper we present our data on laser biostimulation, the combination of pharmacological treatments Solcoseryl TM (SS) and Polygen TM (PG) with light therapy using in-vitro and in-vivo models. In-vitro experiments indicate the ability of laser photons and pharmacological agents SS or PG to augment or abate the cloning efficiency of various cell lines. In-vivo studies focused on the dosimetry of various laser wavelengths and the use of wound healing drugs and 632.8nm laser in wound healing. The application of pharmacological treatments combined with laser therapy reveals the utility of light-drug treatment combinations. Given the ever-increasing cost of medical care, the burden incurred on patients, caregivers and society, this line of research fulfills the increasing need to develop treatment methods that enhance wound healing, especially in situations involving resistance to healing. Key Words: Laser Therapy, wound healing, growth factors.
IntroductionDuring the last decade, a growing interest in Photomedicine has emerged from the creative use of lasers, giving rise to the field of "Laser Biostimulation" or "Low Level Laser Therapy". This form of therapy is now widely used for the treatment of a variety of conditions, including wound healing, reduction of edema and pain of various etiologies.Wound healing photons and its dosimetric parameters have been studied extensively in our laboratory using various lasers: HeCd (442nm), Argon (488-514nm), HeNe (632.8nm), Krypton (670nm), GaAlAs (780nm and 830nm) and CO 2 (10,600nm).(1-4) Our studies suggest that HeNe 632.8nm is the best laser for biostimulation and that laser acceleration of wound healing cannot be attributed to laser skin transmission. (5) We determined the effect of 632.8nm laser in-vitro and invivo with SS, a calf hemodialysate and PG, a cocktail of growth factors and growth hormone (GH). Our in-vitro studies support the use of combined laser+SS (Al-Watban et al., in press) and laser+PG treatments in a nutrient deficient medium.(6) Our in-vivo studies on normal rats have shown that laser+SS or laser+PG minimally accelerate wound healing when compared to the single effect of 632.8nm laser (Al-Watban et al, in press). As a follow-up to our previous studies, we now present a report on a study in which we used an impaired wound healing model to further test the efficacy of laser+drug therapy.The need to promote wound healing, especially during a state of impairment, is imperative due to the ever-increasing cost of medical care and the burden imposed on patients, health care services and society, in general.
Materials and Methods
In-vivo ExperimentsAnimals: A number of male Sprague-Dawley rats were used in this study. The animals were originally imported from Charles River Co., UK in 1984. Now they are bred and provid...